P421 SER-287, an investigational microbiome therapeutic, induces remission and endoscopic improvement in a placebo-controlled, double-blind randomised trial in patients with active mild-to-moderate ulcerative colitis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.